The Powerball jackpot rose to $375 million with a cash value of $170.8 million ahead of the Wednesday, July 1, drawing. Since launching in 1992, Powerball jackpots have been hit more than 400 times.

HARROWSMITH — It’s the Monday after the festivities, and Line Spike Frontenac founder and lead organizer Jeremy Campbell’s enthusiasm won’t be curbed by a lower than expected turnout. The second ...

No one won the $360 million Powerball jackpot in the Monday, June 29, 2026, drawing. The winning numbers for Monday's drawing were 10, 14, 41, 53, 59, with a Powerball of 3. The Powerball jackpot for ...

WASHINGTON — More than 1 million people enrolled in Obamacare plans lack Social Security Numbers, Health and Human Services Secretary Robert F. Kennedy Jr. announced with Centers for Medicare & ...

The Powerball jackpot is growing to an estimated $360 million, with a cash value of $163.8 million for the Monday, June 29, drawing. No one took home the top prize of $346 million for the Saturday, ...

Powerball winning numbers are in for the Saturday, June 27 drawing with a jackpot that reached an estimated $348 million ($158.3 million cash option). The winning numbers in Saturday's drawing are 3, ...

A lucky winner has scooped a massive £9.2 million jackpot in tonight's National Lottery draw. The life-changing sum has been awarded to a player who matched all six numbers in this evening's draw. One ...

No one won the Powerball jackpot for the drawing on Saturday, June 27, 2026. The winning numbers were 3, 16, 28, 30, 59, with a Powerball of 11. Two tickets sold in Arizona and Tennessee matched five ...

The Powerball winning numbers are in for the Saturday, June 27 drawing with a jackpot that reached an estimated $346.4 million ($158.3 million cash value). The drawing, originally scheduled for 10:59 ...

The teacher wrote in large letters on the blackboard. V − E + F = 2 "Today we will study Euler's formula." The atmosphere in the classroom was peaceful. A regular tetrahedron. A regular hexahedron. A ...

Please provide your email address to receive an email when new articles are posted on . Sacituzumab govitecan-hziy is approved for adults with triple-negative breast cancer across PD-L1 status. The ...

Monotherapy in immunotherapy-ineligible patients improved median PFS to 9.7 vs 6.9 months versus physician’s-choice chemotherapy, with 50% vs 47% objective response rates. Combination therapy in PD-L1 ...